Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 147.46 USD 1.91% Market Closed
Market Cap: 7.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+22%
Revenue
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

CRL Price Targets Summary
Charles River Laboratories International Inc

Wall Street analysts forecast CRL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRL is 160.55 USD with a low forecast of 70.7 USD and a high forecast of 225.75 USD.

CRL Lowest Forecast
Wall Street Target
70.7 USD
52% Downside
CRL Average Forecast
Wall Street Target
160.55 USD
9% Upside
CRL Highest Forecast
Wall Street Target
225.75 USD
53% Upside
Lowest
Price Target
70.7 USD
52% Downside
Average
Price Target
160.55 USD
9% Upside
Highest
Price Target
225.75 USD
53% Upside
Charles River Laboratories International Inc Competitors:
Price Targets
T
TEM
Tempus AI Inc
2% Upside
GSS
Genetic Signatures Ltd
78% Upside
MTD
Mettler-Toledo International Inc
7% Upside
CGEN
Compugen Ltd
260% Upside
T
TEM
Tempus AI Inc
2% Upside
GSS
Genetic Signatures Ltd
78% Upside
MTD
Mettler-Toledo International Inc
7% Upside
CGEN
Compugen Ltd
260% Upside
207940
Samsung Biologics Co Ltd
36% Upside
R
301333
R&G PharmaStudies Co Ltd
32% Upside
1SXP
SCHOTT Pharma AG & Co KgaA
6% Upside
300404
Boji Medical Technology Co Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's revenue is 12%. The projected CAGR for the next 3 years is 2%.

12%
Past Growth
2%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's operating income is 10%. The projected CAGR for the next 3 years is 13%.

10%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's net income is -29%. The projected CAGR for the next 3 years is 277%.

-29%
Past Growth
277%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

See Also

Summary
CRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRL stock valuation using valuation multiples.
Wall Street Estimates
CRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRL's stock price target?
Price Target
160.55 USD

According to Wall Street analysts, the average 1-year price target for CRL is 160.55 USD with a low forecast of 70.7 USD and a high forecast of 225.75 USD.

What is Charles River Laboratories International Inc's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's revenue is 12%. The projected CAGR for the next 3 years is 2%.

What is Charles River Laboratories International Inc's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's operating income is 10%. The projected CAGR for the next 3 years is 13%.

What is Charles River Laboratories International Inc's Net Income forecast?
Projected CAGR
277%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's net income is -29%. The projected CAGR for the next 3 years is 277%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.